Bayer added that it would submit an application to the European Medicines Agency for an extension of the Xarelto marketing authorisation. It did not give a timeframe.
Bayer seeks approval to treat children with blockbuster drug Xarelto
More from Industry NewsMore posts in Industry News »
- Sanofi and Translate Bio start clinical trial for mRNA flu vaccine
- Dr Reddy’s Laboratories launches Icosapent Ethyl Capsules in US
- Bharat Biotech’s Covaxin gets SEC approval on its Phase 3 trials efficacy data
- Covid-19 has highlighted the Indian pharma industry’s potential in transforming into an innovation hub: Sudarshan Jain